Pain in Oncolgy: Evaluation of a Non Invasive Monitoring Device (ANI). A Monocentric Prospective Study

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02902627

Acronym

ANIONCO

Enrollment

Registered

2016-09-16

Start date

2012-08-31

Completion date

2016-08-31

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Pain

Brief summary

l'ANI (Analgesia Nociception Index The main objective of the research is to estimate the Analgesia Nociception Index (ANI) as a parameter giving the possibility of measuring the pain in painful metastatic cancer. The parameter ANI is compared with visual analogical scale (VAS) score.

Interventions

DEVICENon Invasive Monitoring Device (ANI)

Pain measure by ANI monitor and with visual analogical scale

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

OTHER

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* more than 18 years, -no legal protection, - * life expectancy is considered over 3-months * not receiving of béta-blocking, * Having a rhythm sinusal without extrasystole * benefiting from a coverage by a social security system

Exclusion criteria

* Pace-Maker * Diabetes mellitus

Design outcomes

Primary

Measure	Time frame
Comparison of the ANI parameter with the VAS	4 hours

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026